Photodynamic therapy of early esophageal cancer.
In 1992-2006 at P.A. Hertsen Moscow Oncology Research Institute photodynamic therapy (PDT) was performed in 48 esophageal cancer patients (total 48 lesions). For PDT we used Russian photosensitizers (Photogem, Photosens, Radachlorin, Alasens), Russian diode lasers (Crystall) and endoscopic equipment. As a result of PDT complete regression was in 77% of esophageal cancer lesions, partial regression was in 23%. The follow-up period was 3-11 years. Median of survival was in 4.59 years of esophageal cancer patient.
Filonenko
Elena V
EV
P.A. Hertsen Moscow Oncology Research Institute, Botkinskii pr., 3, Moscow 125284, Russia. DERKUL23@yandex.ru
Sokolov
Victor V
VV
Chissov
Valery I
VI
Lukyanets
Evgeny A
EA
Vorozhtsov
Georgy N
GN
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010778:Photochemotherapy; D016896:Treatment Outcome